Recursion Pharmaceuticals obtient les autorisations réglementaires pour deux essais de médicaments 16:23 MT Recursion annonce l'avancement de deux médicaments oncologiques expérimentaux clés vers des ...
Hi, everybody. My name is Chris Gibson, Co-Founder and CEO of Recursion, and I'm delighted to welcome you to our earnings call this morning. Recursion Pharmaceuticals : perte nette en hausse au ...
일부 결과는 사용자가 액세스할 수 없으므로 숨겨졌습니다.
액세스할 수 없는 결과 표시
피드백